Just In - ClassifiedPolitics

Pfizer & BioNTech To Consider ‘Future Vaccine Relaunch’ as The Omicron Covid Variant Surges


The Pfizer-BioNTech vaccine is already under scrutiny for the waning efficacy of its mRNA prophylactic therapeutic, which has been marketed as a ‘vaccine’ for Covid-19. The pharmaceutic company, whose Comirnaty vaccine was “fully authorized” for Covid-19 by the Food and Drug Administration was granted full liability shielding by the Biden administration. The so-called ‘vaccines’ (should read Proteinic Inhibitor) have worn off so fast that the Centers for Disease Control is already recommending “boosters.” “BioNTech SE said on Friday it expects more data on a worrying new coronavirus variant detected in South Africa within two weeks to help determine whether its…

This content is for Q17c Membership, Classified Membership, and LifeTime Patriot Membership members only.
Login Join Now
QNavy is a pool of 3 former Navy Officers, U.S. Navy & French Navy, who served proudly their countries, specialized in conflict analysis as per their respective skills & experience on Special Ops. #NavyVetUnited

Yemen: Saudi Warplanes Bomb Sana, The Yemeni Capital, Casualties Reported

Previous article

TikTok Tics: The Rare Worldwide Childhood Syndrome

Next article

You may also like


Comments are closed.